期刊文献+

类风湿关节炎合并心血管疾病的研究进展 被引量:5

Research progress on the risk of cardiovascular disease in patients with rheumatoid arthritis
下载PDF
导出
摘要 类风湿关节炎(RA)患者心血管疾病(CVD)的风险高于年龄和性别相匹配的一般人群的1.5~2.0倍。因全身慢性炎症导致的心血管风险增高是RA的特征之一。RA最优化心血管风险管理的挑战包括改进预测心血管风险的方法和确定目标危险因素以减少心血管风险。从RA研究中吸取经验教训,对于一般人群同样收益,因为炎症在动脉粥样硬化的发病机制中有着重要作用。 The risk of cardiovascular disease in patients with rheumatoid arthritis is 1.5-fold and 2. 0-fold higher than matched general population. This excess risk is attributed to the systemic chronic innammation which is a hallmark of RA. Challenges to optimizing CV risk management in RA include the need for improved methods to predict CV risk,and defining the target risk factors to reduce CV risk. Lessons learned from RA studies can also inform CV risk prevention in the general population, where inflammation also plays an important role in the pathogenesis of atherosclerosis.
出处 《安徽医药》 CAS 2018年第1期8-12,共5页 Anhui Medical and Pharmaceutical Journal
关键词 心血管疾病 类风湿关节炎 炎症 血脂 脂蛋白 cardiovascular disease rheumatoid arthritis inflammation lipids lipoproteins
  • 相关文献

参考文献1

二级参考文献27

  • 1Avina-Zubieta JA, Thomas J, Sadatsafavi M, et al. Risk of incident cardiovascular events in patients with rheumatoid 'arthritis : a meta-analysis of observational studies[ J]. Ann Rheum Dis,2012,71(9) : 1524-1529.
  • 2Naranjo A, Sokka T, Descalzo MA,et al. Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study [ J ]. Arthritis Res Ther,2008, 10 ( 2 ) : R30.
  • 3Maradit-Kremers H, Crowson CS, Nicola PJ, et al. Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study [ J ]. Arthritis Rheum ,2005,52 ( 2 ) :402-411.
  • 4Shoenfeld Y, Gerli R, Doria A, et al. Accelerated atherosclerosis in autoimmune rheumatic diseases [ J ]. Circulation, 2005, 112 (21) :3337-3347.
  • 5Avina-Zubieta JA, Choi HK, Sadatsafavi M, et at. Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies[ J]. Arthritis Rheum,2008, 59(12) :1690-1697.
  • 6Chung CP, Giles JT, Petri M, et al. Prevalence of traditional modifiable cardiovascular risk factors in patients with rhemnatoid arthritis: comparison with control subjects from the muhi-ethnic study of atherosclerosis [ J]. Semin Arthritis Rheum, 2012,41 (4) :535-544.
  • 7Georgiadis AN, Papavasiliou EC, Lourida ES, et al. Atherogenic lipid profile is a feature characteristic of patients with early rheumatoid arthritis: effect of early treatment--a prospective, controlled study[ J ]. Arthritis Res Ther, 2006,8 (3) : R82.
  • 8Daien CI, Duny Y, Bametche T, et al. Effect of TNF inhibitors on lipid profile in rheumatoid arthritis : a systematic review with meta- analysis[ J]. Ann Rheum Dis,2012,71 (6) :862-868.
  • 9Van Lenten BJ, Reddy ST, Navab M, et al. Understanding changes in high density lipoproteins during the acute phase response[ J]. Arterioscler Thromb Vasc Biol,2006,26 ( 8 ) : 1687-1688.
  • 10McMahon M, Grossman J, FitzGerald J, et al. Proinflammatory high-density lipoprotein as a biomarker for atherosclerosis in patients with systemic lupus erythematosus and rheumatoid arthritis [ J ]. Arthritis Rheum, 2006, 54 ( 8 ) :2541-2549.

共引文献8

同被引文献63

引证文献5

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部